Pathological complete response to neoadjuvant pembrolizumab in a patient with metastatic cutaneous squamous cell carcinoma.
Manon BlaiseGilles PoissonnetNathalie Cardot-LecciaAnne SudakaMarine VelinMadleen ChassangMicheline Razzouk-CadetAlexandra Picard-GauciThierry PasseronHenri MontaudiéPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)